MIAMI, Oct. 11, 2016 /PRNewswire/ -- Researchers from Vector Vitale Inc., a Florida (USA) based company, have found that maintaining the right isotope ratio of essential chemical elements representing less than one percent of human body mass is a matter of life and death. Important discoveries allow to understand why and how pathologies are born.
An important discovery of unknown but critical isotope-separation function of both endocrine and immune system was made. Quality and efficiency of proteins produced by endocrine system glands, related organs, tissues and cells is defined by isotope ratios. Hormones, sperm, breast milk etc. are highly enriched with light and depleted of heaviest isotopes of the same chemical elements. The same is true for cells created by the red marrow of bones: lymphocytes, erythrocytes and thrombocytes.
Negative byproduct of isotope selectivity is local accumulation of heavy isotopes within parts of immune and endocrine systems such as red marrow, bones, hypothalamus, pituitary, thyroid, parathyroid, adrenals, pineal body, reproductive organs (ovaries and testes), pancreas, mammary glands, prostate or in other cells that produce hormones (of the stomach, small intestine, skin). Dramatic shift of isotope ratios in favor of heaviest isotopes is a signature of blood cancer cells and solid malignant tumors.
Said accumulation of heavy isotopes and shift in isotope ratios away from standard natural abundance starts from the substitution of lightest isotope by the heaviest of the same chemical element in macromolecules. This event represents the very first step of pathogenesis – a missing and decisive piece to understand causes of various diseases.
Preclinical research conducted in cooperation with specialized academic institutions has confirmed high efficiency of isotope-selective treatment in curing most dangerous pathologies including leukemia; lung, kidneys and breast cancers as wells as in elimination of bacterial and viral infections: Staphylococcus aureus; E. coli; P. aeruginosa; Herpes 1 and 2, Epstein-Barr disease, Hepatitis C.
Vector Vitale's new isotope-selective Medicine represents a new standard for successful treatment and prevention of degenerative and infectious diseases.
The scientists from Vector Vitale emphasize on the uniqueness of their isotope-selective treatment and believe it is the only truly efficient method to simultaneously regenerate both immune and endocrine systems shifting human organism back in time to healthy/pre-disease and youthful state with permanent universal protection against degenerative pathologies including cancer, diabetes, Alzheimer's, Parkinson's diseases and various infections. It opens new horizons for anti-aging therapies.
SOURCE Vector Vitale Inc.